A novel radiation-induced mutation at the end of the DNA binding domain of p53 has not been demonstrated to play a role in radiation-induced radioresistance on lung cancer cell lines, as evidenced by Sun and collaborators [54,55]. The gene discussed is TP53; the disease is lung carcinoma.